AA
MDCO
Antipodean Advisors’s Medicines Co MDCO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-321,000
| Closed | -$27.3M | – | 9 |
|
2019
Q4 | $27.3M | Hold |
321,000
| – | – | 15.6% | 3 |
|
2019
Q3 | $16.1M | Buy |
321,000
+64,000
| +25% | +$3.2M | 13.39% | 5 |
|
2019
Q2 | $9.37M | Buy |
257,000
+87,000
| +51% | +$3.17M | 11.4% | 4 |
|
2019
Q1 | $4.75M | Buy |
170,000
+41,000
| +32% | +$1.15M | 3.38% | 6 |
|
2018
Q4 | $2.47M | Buy |
129,000
+47,000
| +57% | +$900K | 4.68% | 6 |
|
2018
Q3 | $2.45M | Sell |
82,000
-83,500
| -50% | -$2.5M | 3.04% | 8 |
|
2018
Q2 | $6.07M | Sell |
165,500
-72,000
| -30% | -$2.64M | 7.66% | 6 |
|
2018
Q1 | $7.82M | Buy |
237,500
+139,500
| +142% | +$4.59M | 8.65% | 5 |
|
2017
Q4 | $2.68M | Sell |
98,000
-78,000
| -44% | -$2.13M | 2.18% | 11 |
|
2017
Q3 | $6.52M | Sell |
176,000
-398,434
| -69% | -$14.8M | 5.5% | 8 |
|
2017
Q2 | $21.8M | Sell |
574,434
-256,000
| -31% | -$9.73M | 12.28% | 1 |
|
2017
Q1 | $40.6M | Buy |
830,434
+598,000
| +257% | +$29.2M | 19.82% | 1 |
|
2016
Q4 | $7.89M | Sell |
232,434
-50,000
| -18% | -$1.7M | 3.16% | 11 |
|
2016
Q3 | $10.7M | Sell |
282,434
-184,789
| -40% | -$6.97M | 5.27% | 10 |
|
2016
Q2 | $15.7M | Sell |
467,223
-255,000
| -35% | -$8.58M | 9.5% | 2 |
|
2016
Q1 | $22.9M | Sell |
722,223
-1,023,077
| -59% | -$32.5M | 10.4% | 2 |
|
2015
Q4 | $65.2M | Sell |
1,745,300
-692,700
| -28% | -$25.9M | 9.51% | 4 |
|
2015
Q3 | $92.5M | Buy |
+2,438,000
| New | +$92.5M | 10.54% | 4 |
|